Requesting a Sample Copy of This Report, Please Visit: http://www.qyresearchreports.us/request-sample/global-heparin-sodium-market-by-manufacturers-countries-type-and-application-forecast-to-2022
Heparin Sodium Injection, USP is a sterile, nonpyrogenic solution of heparin sodium (derived from porcine intestinal mucosa) in water for injection. Each container contains 10000, 12500, 20000 or 25,000 USP Heparin Units; 40 or 80 mg sodium chloride added to render isotonic (see HOW SUPPLIED section for various sizes and strength). May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. pH 6.0 (5.0 to 7.5).
The solution contains no bacteriostat, antimicrobial agent or added buffer and is intended for use only as a single-dose injection. When smaller doses are required, the unused portion should be discarded.
Heparin sodium in the ADD-Vantage™ system is intended for intravenous administration only after dilution.
Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots.
Scope of the Report:
This report focuses on the Heparin Sodium in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Changzhou Qianhong Bio-pharma
To Know More About This Report, Click Here: http://www.qyresearchreports.us/market-analysis/global-heparin-sodium-market-by-manufacturers-countries-type-and-application-forecast-to-2022
There are 15 Chapters to deeply display the global Heparin Sodium market.
Chapter 1, to describe Heparin Sodium Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Heparin Sodium, with sales, revenue, and price of Heparin Sodium, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Heparin Sodium, for each region, from 2012 to 2017;
Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
11323 136th Ave East
Puyallup, Wa 98374
Email – Sales@Qyresearchreports.Us